Will Dendreon Break FDA and Wall Street Stranglehold on Cancer?

Tomorrow, April 28, 2009, at long last the day of reckoning for Immunotherapy is upon us. Dendreon will present its statistically significant Impact trial results on Provenge at the American Urological...